Cite
HARVARD Citation
Ran, D. et al. (2017). A randomized, controlled comparison of different intensive lipid-lowering therapies in Chinese patients with non-ST-elevation acute coronary syndrome (NSTE-ACS): Ezetimibe and rosuvastatin versus high-dose rosuvastatin. International journal of cardiology. pp. 49-55. [Online].